|
1
|
Menendez JA and Lupu R: Fatty acid
synthase and the lipogenic phenotype in cancer pathogenesis. Nat
Rev Cancer. 7:763–777. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alò PL, Visca P, Trombetta G, Mangoni A,
Lenti L, Monaco S, Botti C, Serpieri DE and Di Tondo U: Fatty acid
synthase (FAS) predictive strength in poorly differentiated early
breast carcinomas. Tumori. 85:35–40. 1999.PubMed/NCBI
|
|
3
|
Shurbaji MS, Kalbfleisch JH and Thurmond
TS: Immunohistochemical detection of a fatty acid synthase (OA-519)
as a predictor of progression of prostate cancer. Hum Pathol.
27:917–921. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gansler TS, Hardman W III, Hunt DA,
Schaffel S and Hennigar RA: Increased expression of fatty acid
synthase (OA-519) in ovarian neoplasms predicts shorter survival.
Hum Pathol. 28:686–692. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Visca P, Sebastiani V, Botti C, Diodoro
MG, Lasagni RP, Romagnoli F, Brenna A, De Joannon BC, Donnorso RP,
Lombardi G, et al: Fatty acid synthase (FAS) is a marker of
increased risk of recurrence in lung carcinoma. Anticancer Res.
24:4169–4173. 2004.
|
|
6
|
Mashima T, Seimiya H and Tsuruo T: De novo
fatty-acid synthesis and related pathways as molecular targets for
cancer therapy. Br J Cancer. 100:1369–1372. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Knowles LM, Yang C, Osterman A and Smith
JW: Inhibition of fatty-acid synthase induces caspase-8-mediated
tumor cell apoptosis by up-regulating DDIT4. J Biol Chem.
283:31378–31384. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brusselmans K, De Schrijver E, Heyns W,
Verhoeven G and Swinnen JV: Epigallocatechin-3-gallate is a potent
natural inhibitor of fatty acid synthase in intact cells and
selectively induces apoptosis in prostate cancer cells. Int J
Cancer. 106:856–862. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Puig T, Vázquez-Martín A, Relat J, Pétriz
J, Menéndez JA, Porta R, Casals G, Marrero PF, Haro D, Brunet J, et
al: Fatty acid metabolism in breast cancer cells: Differential
inhibitory effects of epigallocatechin gallate (EGCG) and C75.
Breast Cancer Res Treat. 109:471–479. 2008. View Article : Google Scholar
|
|
10
|
Ruby AJ, Kuttan G, Babu KD, Rajasekharan
KN and Kuttan R: Anti-tumour and antioxidant activity of natural
curcuminoids. Cancer Lett. 94:79–83. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moragoda L, Jaszewski R and Majumdar AP:
Curcumin induced modulation of cell cycle and apoptosis in gastric
and colon cancer cells. Anticancer Res. 21:873–878. 2001.PubMed/NCBI
|
|
12
|
Bush JA, Cheung KJ Jr and Li G: Curcumin
induces apoptosis in human melanoma cells through a Fas
receptor/caspase-8 pathway independent of p53. Exp Cell Res.
271:305–314. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Radhakrishna Pillai G, Srivastava AS,
Hassanein TI, Chauhan DP and Carrier E: Induction of apoptosis in
human lung cancer cells by curcumin. Cancer Lett. 208:163–170.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chainani-Wu N: Safety and
anti-inflammatory activity of curcumin: A component of tumeric
(Curcuma longa). J Altern Complement Med. 9:161–168. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Syng-Ai C, Kumari AL and Khar A: Effect of
curcumin on normal and tumor cells: Role of glutathione and bcl-2.
Mol Cancer Ther. 3:1101–1108. 2004.PubMed/NCBI
|
|
16
|
Anand P, Sundaram C, Jhurani S,
Kunnumakkara AB and Aggarwal BB: Curcumin and cancer: An 'old-age'
disease with an 'age-old' solution. Cancer Lett. 267:133–164. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao J, Sun XB, Ye F and Tian WX:
Suppression of fatty acid synthase, differentiation and lipid
accumulation in adipocytes by curcumin. Mol Cell Biochem.
351:19–28. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Milgraum LZ, Witters LA, Pasternack GR and
Kuhajda FP: Enzymes of the fatty acid synthesis pathway are highly
expressed in in situ breast carcinoma. Clin Cancer Res.
3:2115–2120. 1997.
|
|
19
|
Kuhajda FP: Fatty acid synthase and
cancer: New application of an old pathway. Cancer Res.
66:5977–5980. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pizer ES, Wood FD, Heine HS, Romantsev FE,
Pasternack GR and Kuhajda FP: Inhibition of fatty acid synthesis
delays disease progression in a xenograft model of ovarian cancer.
Cancer Res. 56:1189–1193. 1996.PubMed/NCBI
|
|
21
|
Kuhajda FP: Fatty-acid synthase and human
cancer: New perspectives on its role in tumor biology. Nutrition.
16:202–208. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Flavin R, Peluso S, Nguyen PL and Loda M:
Fatty acid synthase as a potential therapeutic target in cancer.
Future Oncol. 6:551–562. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hatcher H, Planalp R, Cho J, Torti FM and
Torti SV: Curcumin: From ancient medicine to current clinical
trials. Cell Mol Life Sci. 65:1631–1652. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hermine O, Haioun C, Lepage E, d'Agay MF,
Briere J, Lavignac C, Fillet G, Salles G, Marolleau JP, Diebold J,
et al: Prognostic significance of bcl-2 protein expression in
aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de
l'Adulte (GELA). Blood. 87:265–272. 1996.PubMed/NCBI
|
|
25
|
Anto RJ, Maliekal TT and Karunagaran D:
L-929 cells harboring ectopically expressed RelA resist
curcumin-induced apoptosis. J Biol Chem. 275:15601–15604. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Doglioni C, Dei Tos AP, Laurino L,
Chiarelli C, Barbareschi M and Viale G: The prevalence of BCL-2
immunoreactivity in breast carcinomas and its clinicopathological
correlates, with particular reference to oestrogen receptor status.
Virchows Arch. 424:47–51. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Onodera J, Nakamura S, Nagano I, Tobita M,
Yoshioka M, Takeda A, Oouchi M and Itoyama Y: Upregulation of Bcl-2
protein in the myasthenic thymus. Ann Neurol. 39:521–528. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Salakou S, Tsamandas AC, Bonikos DS,
Papapetropoulos T and Dougenis D: The potential role of bcl-2, bax,
and Ki67 expression in thymus of patients with myasthenia gravis,
and their correlation with clinicopathologic parameters. Eur J
Cardiothorac Surg. 20:712–721. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Oltvai ZN, Milliman CL and Korsmeyer SJ:
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that
accelerates programmed cell death. Cell. 74:609–619. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang E and Korsmeyer SJ: Molecular
thanatopsis: A discourse on the BCL2 family and cell death. Blood.
88:386–401. 1996.PubMed/NCBI
|
|
31
|
Korsmeyer SJ: BCL-2 gene family and the
regulation of programmed cell death. Cancer Res. 59(Suppl 7):
1693s–1700s. 1999.PubMed/NCBI
|
|
32
|
Testa JR and Bellacosa A: AKT plays a
central role in tumorigenesis. Proc Natl Acad Sci USA.
98:10983–10985. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li S, Zhou Y, Wang R, Zhang H, Dong Y and
Ip C: Selenium sensitizes MCF-7 breast cancer cells to
doxorubicin-induced apoptosis through modulation of phospho-Akt and
its downstream substrates. Mol Cancer Ther. 6:1031–1038. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pizer ES, Chrest FJ, DiGiuseppe JA and Han
WF: Pharmacological inhibitors of mammalian fatty acid synthase
suppress DNA replication and induce apoptosis in tumor cell lines.
Cancer Res. 58:4611–4615. 1998.PubMed/NCBI
|
|
36
|
De Schrijver E, Brusselmans K, Heyns W,
Verhoeven G and Swinnen JV: RNA interference-mediated silencing of
the fatty acid synthase gene attenuates growth and induces
morphological changes and apoptosis of LNCaP prostate cancer cells.
Cancer Res. 63:3799–3804. 2003.PubMed/NCBI
|
|
37
|
Wang HQ, Altomare DA, Skele KL, Poulikakos
PI, Kuhajda FP, Di Cristofano A and Testa JR: Positive feedback
regulation between AKT activation and fatty acid synthase
expression in ovarian carcinoma cells. Oncogene. 24:3574–3582.
2005. View Article : Google Scholar : PubMed/NCBI
|
